UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Nipple sparing subcutaneous mastectomy: Sixty-six months follow-up

European journal of surgical oncology, 2006-11, Vol.32 (9), p.937-940

2006

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab in non small cell lung cancer: development, current status and issues

Current medicinal chemistry, 2012-03, Vol.19 (7), p.961

2012

Link zum Volltext

Verfügbarkeit prüfen

57 WHAT TARGET IN THE TREATMENT OF OF NON-SMALL-CELL LUNG CANCER WITH THREE DIMENSIONAL CONFORMAL RADIOTHERAPY (3D-CRT): ELECTIVE NODAL IRRADIATION (ENI) OR NON-ELECTIVE NODAL IRRADIATION ?

Cancer treatment reviews, 2010, Vol.36, p.S112-S112

2010

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastoma

Oncology reports, 2004-01, Vol.11 (1), p.93

2004

Link zum Volltext

Verfügbarkeit prüfen

Clinical benefit of intermittent administration of imatinib in a patient with metastatic gastrointestinal stromal tumour

Clinical oncology (Royal College of Radiologists (Great Britain)), 2005-04, Vol.17 (2), p.96-97

2005

Link zum Volltext

Verfügbarkeit prüfen

Vandetanib: An overview of its clinical development in NSCLC and other tumors

Drugs of today (Barcelona, Spain : 1998), 2010-09, Vol.46 (9), p.683-698

2010

Link zum Volltext

Verfügbarkeit prüfen

Use of trastuzumab associated with cisplatin and vinorelbine followed by docetaxel as a neoadjuvant regimen for patients with HER2-positive breast cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.637-637

2010

Link zum Volltext

Verfügbarkeit prüfen

Relapsed Colon Cancer

The New England journal of medicine, 2005-09, Vol.353 (12), p.1274-1274

2005

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant trastuzumab in a sequential nonanthracycline-based regimen for patients with stage II-III breast cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e11559-e11559

2009

Link zum Volltext

Verfügbarkeit prüfen

Fulvestrant in metastatic breast cancer: Safety, efficacy, and role as mainteinance therapy for heavily pretreated patients

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.1133-1133

2008

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer

Oncology reports, 2006-08, Vol.16 (2), p.393-398

2006

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide is inactive in heavily pretreated patients with metastatic breast cancer

The cancer journal (Sudbury, Mass.), 2005-05, Vol.11 (3), p.248

2005

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic challenges in patients with tumors: case 2. Staphylococcal scalded-skin syndrome in a patient with extended small-cell lung cancer

Journal of clinical oncology, 2003-10, Vol.21 (19), p.3702-3703

2003

Link zum Volltext

Verfügbarkeit prüfen

Association of weekly gemcitabine to conformal radiotherapy as organ-sparing strategy in locally advanced or relapsed bladder cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.15570-15570

2007

Link zum Volltext

Verfügbarkeit prüfen

PCN36 ECONOMIC EVALUATION OF ERLOTINIB, DOCETAXEL AND PEMETREXEDAS SECOND LINE TREATMENT IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC). A COST-MINIMIZATION IN ITALIAN HOSPITALS

Value in health, 2007, Vol.10 (6), p.A333-A333

2007

Link zum Volltext

Verfügbarkeit prüfen

Valutazione economica di erlotinib, docetaxel e pemetrexed nel trattamento di seconda linea del carcinoma polmonare non a piccole cellule

PharmacoEconomics. Italian research articles, 2007-07, Vol.9 (2), p.113-124

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of celecoxib and weekly paclitaxel in the treatment of pretreated advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7337-7337

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of celecoxib and weekly paclitaxel in the treatment of pretreated advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7337-7337

2004

Link zum Volltext

Verfügbarkeit prüfen

Rofecoxib associated with weekly irinotecan and infusional 5-fluorouracil as second-line treatment for metastatic colorectal cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3686-3686

2004

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine, vinorelbine and trastuzumab combination (GemVinT) as second-third line therapy for HER-2 overexpressing metastatic breast cancer (MBC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.759-759

2004

Link zum Volltext

Verfügbarkeit prüfen

Rofecoxib associated with weekly irinotecan and infusional 5-fluorouracil as second-line treatment for metastatic colorectal cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3686-3686

2004

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine, vinorelbine and trastuzumab combination (GemVinT) as second-third line therapy for HER-2 overexpressing metastatic breast cancer (MBC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.759-759

2004

Link zum Volltext

Verfügbarkeit prüfen

An unusual case of three synchronous tumors in a young woman

Tumori, 2005-05, Vol.91 (3), p.267-269

2005

Link zum Volltext

Verfügbarkeit prüfen

Solitary ganglioneuroma of the ileo-cecal valve

Pathologica, 2003-08, Vol.95 (4), p.192

2003

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic challenges in patients with tumors

Journal of clinical oncology, 2003, Vol.21 (19), p.3700-3705

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(25)

Sprache

Englisch
(23)
Italienisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nipple sparing subcutaneous mastectomy: Sixty-six months follow-up

Bevacizumab in non small cell lung cancer: development, current status and issues

57 WHAT TARGET IN THE TREATMENT OF OF NON-SMALL-CELL LUNG CANCER WITH THREE DIMENSIONAL CONFORMAL RADIOTHERAPY (3D-CRT): ELECTIVE NODAL IRRADIATION (ENI) OR NON-ELECTIVE NODAL IRRADIATION ?

Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastoma

Clinical benefit of intermittent administration of imatinib in a patient with metastatic gastrointestinal stromal tumour

Vandetanib: An overview of its clinical development in NSCLC and other tumors

Use of trastuzumab associated with cisplatin and vinorelbine followed by docetaxel as a neoadjuvant regimen for patients with HER2-positive breast cancer

Relapsed Colon Cancer

Neoadjuvant trastuzumab in a sequential nonanthracycline-based regimen for patients with stage II-III breast cancer

Fulvestrant in metastatic breast cancer: Safety, efficacy, and role as mainteinance therapy for heavily pretreated patients

Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer

Thalidomide is inactive in heavily pretreated patients with metastatic breast cancer

Diagnostic challenges in patients with tumors: case 2. Staphylococcal scalded-skin syndrome in a patient with extended small-cell lung cancer

Association of weekly gemcitabine to conformal radiotherapy as organ-sparing strategy in locally advanced or relapsed bladder cancer

PCN36 ECONOMIC EVALUATION OF ERLOTINIB, DOCETAXEL AND PEMETREXEDAS SECOND LINE TREATMENT IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC). A COST-MINIMIZATION IN ITALIAN HOSPITALS

Valutazione economica di erlotinib, docetaxel e pemetrexed nel trattamento di seconda linea del carcinoma polmonare non a piccole cellule

Phase II study of celecoxib and weekly paclitaxel in the treatment of pretreated advanced non-small cell lung cancer (NSCLC)

Phase II study of celecoxib and weekly paclitaxel in the treatment of pretreated advanced non-small cell lung cancer (NSCLC)

Rofecoxib associated with weekly irinotecan and infusional 5-fluorouracil as second-line treatment for metastatic colorectal cancer

Gemcitabine, vinorelbine and trastuzumab combination (GemVinT) as second-third line therapy for HER-2 overexpressing metastatic breast cancer (MBC)

Rofecoxib associated with weekly irinotecan and infusional 5-fluorouracil as second-line treatment for metastatic colorectal cancer

Gemcitabine, vinorelbine and trastuzumab combination (GemVinT) as second-third line therapy for HER-2 overexpressing metastatic breast cancer (MBC)

An unusual case of three synchronous tumors in a young woman

Solitary ganglioneuroma of the ileo-cecal valve

Diagnostic challenges in patients with tumors

Suchergebnisse filtern